Moderna Vaccine Booster

Moderna, bird flu and mRNA

Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

health.wusf.usf.edu · 9h

U.S. pays $590 million to Moderna to speed up development of bird flu vaccine

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.

Medical Xpress · 21h

US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

CNN on MSN · 1d

HHS invests nearly $600 million in Moderna’s bird flu vaccine development

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

Seeking Alpha · 1d

Moderna gets $590M HHS contract to develop mRNA pandemic flu vaccines

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.

MercoPress2d

COVID-19 booster shots are better if specific brands are used

researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

1don MSN

Moderna Gets $590 Million of Federal Funding For Influenza Vaccines

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares tumble

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

Monthly Prescribing Reference4d

Moderna Provides Update on Norovirus Vaccine Candidate

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

2don MSN

Northeast Ohio pediatrician’s office working with Moderna on a potential mono vaccine

The research team at Senders Pediatrics is working with Moderna to study a vaccine developed for Epstein-Barr Virus, which ...

FiercePharma5d

JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

2don MSN

CDC upgrades its advisory on bird flu. Will Moderna’s stock get a boost?

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

2don MSN

Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?

The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results